Wednesday, January 14, 2009

Barr challenges Medicis over Solodyn

FDANews reported on 14 Jan 09: Medicis Pharmaceutical has received notice that Barr Laboratories has filed an ANDA to market a generic version of Medicis’ once-daily, oral acne treatment Solodyn — a drug that is the subject of a citizen petition.

See previous IPBiz post:

Medicis does deal with Impax over Solodyn


Post a Comment

<< Home